Li X - Search Results

1

Aberration of p73 promoter methylation in de novo myelodysplastic syndrome.

Zhao Y, Gu S, Guo J, Zhang Z, Zhang X, Li X, Chang C. Zhao Y, et al. Among authors: li x. Hematology. 2012 Sep;17(5):275-82. doi: 10.1179/1607845412Y.0000000018. Hematology. 2012. PMID: 22971533 Free article. Clinical Trial.

2

[Recent advances of molecular mechanisms influencing prognosis of myelodysplastic syndrome - review].

Guo J, Chang CK, Li X. Guo J, et al. Among authors: li x. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012 Aug;20(4):1020-4. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2012. PMID: 22931676 Review. Chinese.

3

The effect of the combination of bisphosphonates and conventional chemotherapy on bone metabolic markers in multiple myeloma patients.

Zhang X, Chang C, Zhao Y, Wu L, Zhang Z, Li X. Zhang X, et al. Among authors: li x. Hematology. 2012 Sep;17(5):255-60. doi: 10.1179/1607845412Y.0000000021. Hematology. 2012. PMID: 22971530 Free article. Clinical Trial.

4

Aberrant promoter methylation of Dab2 gene in myelodysplastic syndrome.

Yang Y, Zhang Q, Xu F, Chang C, Li X. Yang Y, et al. Among authors: li x. Eur J Haematol. 2012 Dec;89(6):469-77. doi: 10.1111/ejh.12014. Epub 2012 Oct 16. Eur J Haematol. 2012. PMID: 23005040

5

Methylation of the p73 gene in patients with myelodysplastic syndromes: correlations with apoptosis and prognosis.

Zhao Y, Fei C, Zhang X, Zhang Y, Guo J, Gu S, Li X, Chang C. Zhao Y, et al. Among authors: li x. Tumour Biol. 2013 Feb;34(1):165-72. doi: 10.1007/s13277-012-0524-y. Epub 2012 Sep 28. Tumour Biol. 2013. PMID: 23055192

6

Interleukin-17 enhances the production of interferon-γ and tumour necrosis factor-α by bone marrow T lymphocytes from patients with lower risk myelodysplastic syndromes.

Zhang Z, Li X, Guo J, Xu F, He Q, Zhao Y, Yang Y, Gu S, Zhang Y, Wu L, Chang C. Zhang Z, et al. Among authors: li x. Eur J Haematol. 2013 May;90(5):375-84. doi: 10.1111/ejh.12074. Epub 2013 Mar 1. Eur J Haematol. 2013. PMID: 23331180

7

[Study of aberrant p73 promoter methylation in patients with myelodysplastic syndrome].

Zhao YS, Yang R, Gu SC, Guo J, Zhang X, Wu LY, Li X, Chang CK. Zhao YS, et al. Among authors: li x. Zhonghua Xue Ye Xue Za Zhi. 2012 Oct;33(10):847-51. Zhonghua Xue Ye Xue Za Zhi. 2012. PMID: 23384909 Chinese.

8

Distinct clinical and experimental characteristics in the patients younger than 60 years old with myelodysplastic syndromes.

Li X, Xiao ZJ, Chang CK, Xu F, Wu LY, He Q, Xu ZF, Song LX, Zhang Z, Zhou LY, Su JY, Zhang X, Guo J. Li X, et al. PLoS One. 2013;8(2):e57392. doi: 10.1371/journal.pone.0057392. Epub 2013 Feb 28. PLoS One. 2013. PMID: 23468979 Free PMC article.

9

Low RPS14 expression in MDS without 5q - aberration confers higher apoptosis rate of nucleated erythrocytes and predicts prolonged survival and possible response to lenalidomide in lower risk non-5q- patients.

Wu L, Li X, Xu F, Zhang Z, Chang C, He Q. Wu L, et al. Among authors: li x. Eur J Haematol. 2013 Jun;90(6):486-93. doi: 10.1111/ejh.12105. Epub 2013 Apr 23. Eur J Haematol. 2013. PMID: 23506134 Clinical Trial.

10

The evaluation of iron overload through hepcidin level and its related factors in myelodysplastic syndromes.

Gu S, Song X, Zhao Y, Guo J, Fei C, Xu F, Wu L, Zhang X, Zhao J, Chang C, Li X. Gu S, et al. Among authors: li x. Hematology. 2013 Sep;18(5):286-94. doi: 10.1179/1607845412Y.0000000064. Epub 2013 Mar 20. Hematology. 2013. PMID: 23540794 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

183,616 results

Search Page

Filters